E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/3/2006 in the Prospect News Biotech Daily.

PDI kept at hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained PDI, Inc. at its hold rating with a $13 price target after company management has taken steps towards the company's recovery by establishing credible cost control measures. Jefferies' revised earnings per share estimates for 2006 and 2007 are $0.55 and $0.31. Shares of the Saddle River, N.J., biopharmaceutical services company were up $0.05, or 0.39%, at $12.87 on volume of 60,673 shares versus the three-month running average of 93,343 shares. (Nasdaq: PDII)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.